Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
New Signatera™ Data in Multiple Myeloma, Colorectal Cancer and Ovarian Cancer Highlights Clinical Utility of MRD in Real-World Settings
09:03am, Wednesday, 26'th May 2021
AUSTIN, Texas, May 26, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new clinical data on its personalized a
Natera to Present Clinical Data from Largest Prospective MRD-Guided Trial in Colorectal Cancer at the 2021 ASCO Annual Meeting
09:03am, Thursday, 20'th May 2021
AUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced initial results from the CIRCULATE-Japan trial, the large
Natera's (NTRA) CEO Steve Chapman on Q1 2021 Results - Earnings Call Transcript
08:50am, Sunday, 09'th May 2021
Natera's (NTRA) CEO Steve Chapman on Q1 2021 Results - Earnings Call Transcript
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
07:32pm, Thursday, 06'th May 2021
Natera (NTRA) delivered earnings and revenue surprises of 29.52% and 31.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Natera: Q1 Earnings Insights
04:47pm, Thursday, 06'th May 2021
Shares of Natera (NASDAQ:NTRA) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 64.44% over the past year to ($0.74), which beat the estima
Natera to Present New Colorectal Cancer and Multiple Myeloma Data at the 2021 Annual ASCO Meeting
09:03am, Monday, 03'rd May 2021
AUSTIN, Texas, May 3, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present 4 posters at the 2021 American Society o
Naturally Splendid appoints CANEX Foods as master distributor for NATERA Plant Based Foods in Canada
09:21am, Friday, 30'th Apr 2021
Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) has appointed CANEX Foods as master distributor for NATERA Plant Based Foods in Canada. Previously, CANEX Foods was a distribut
Natera Announces First Quarter 2021 Earnings Conference Call
09:03am, Thursday, 29'th Apr 2021
AUSTIN, Texas, April 29, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its first quarter
Naturally Splendid says third shipping container of Natera Plant Based Foods has arrived from Australia
09:35am, Friday, 23'rd Apr 2021
Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) has announced that the third shipping container of Natera Plant Based Foods has arrived from Australia. In anticipation of dema
Naturally Splendid says 3rd shipping container of Natera Plant Based Foods has arrived from Australia
09:30am, Friday, 23'rd Apr 2021
Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCPINK:NSPDF) (FRA:50N) has announced that the third shipping container of Natera Plant Based Foods has arrived from Australia. In anticipation of dema
Prospera™ Transplant Assessment Test: Path Established to Expand Future Coverage to Multiple Organs
11:20am, Thursday, 22'nd Apr 2021
AUSTIN, Texas, April 22, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and a global leader in cell-free DNA testing, receives pathway to future coverage for the Prospera donor-derive
Natera Implements First Wave of Panorama® AI Improvements With Immediate Impact on Patient Experience and COGS
09:56am, Wednesday, 07'th Apr 2021
AUSTIN, Texas, April 7, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, has implemented the first wave of Panorama AI innovations following the
Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing
09:07am, Wednesday, 31'st Mar 2021
AUSTIN, Texas, March 31, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab se
FDA Grants Two New Breakthrough Device Designations for Natera's Signatera™ MRD Test
09:03am, Wednesday, 24'th Mar 2021
AUSTIN, Texas, March 24, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the US Food and Drug Administration (FDA) has gra
Natera, Inc. (NTRA) CEO Steve Chapman on Q4 2020 Results - Earnings Call Transcript
05:15am, Sunday, 28'th Feb 2021
Natera, Inc. (NTRA) CEO Steve Chapman on Q4 2020 Results - Earnings Call Transcript
